Glipizide and Post procedural haemorrhage - a phase IV clinical study of FDA data

Summary:

Post procedural haemorrhage is reported as a side effect among people who take Glipizide (glipizide), especially for people who are male, 60+ old, also take Xarelto, and have High blood pressure.

The phase IV clinical study analyzes which people have Post procedural haemorrhage when taking Glipizide. It is created by eHealthMe based on reports of 63,661 people who have side effects when taking Glipizide from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Post procedural haemorrhage?

Post procedural haemorrhage (post procedural bleeding) is found to be associated with 664 drugs and 854 conditions by eHealthMe. Check the latest studies of Post procedural haemorrhage.

On Jul, 09, 2026

63,661 people reported to have side effects when taking Glipizide.
Among them, 56 people (0.09%) have Post procedural haemorrhage.

Could Glipizide cause Post procedural haemorrhage?

Among these 56 people:

What is the gender of people who have Post procedural haemorrhage when taking Glipizide? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Post procedural haemorrhage when taking Glipizide? *

What are other drugs people take besides Glipizide? *

Xarelto: 13 people, 23.21%
Lasix: 12 people, 21.43%
Vitamin D3: 10 people, 17.86%
Furosemide: 9 people, 16.07%
Oxycontin: 9 people, 16.07%
Metformin: 9 people, 16.07%
Methylprednisolone: 8 people, 14.29%
Loperamide Hydrochloride: 8 people, 14.29%
Aspirin: 8 people, 14.29%
Levoxyl: 7 people, 12.50%

What are other side effects people have besides Post procedural haemorrhage? *

Pain: 12 people, 21.43%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 11 people, 19.64%
Tremor (trembling or shaking movements in one or more parts of your body): 10 people, 17.86%
Acute Kidney Failure: 9 people, 16.07%
Drug Ineffective: 8 people, 14.29%
Post Procedural Complication: 8 people, 14.29%
Haemorrhage (bleeding): 8 people, 14.29%
Gallstones (stone formation by bile component): 8 people, 14.29%
Dehydration (dryness resulting from the removal of water): 7 people, 12.50%
Fall: 7 people, 12.50%

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 17.86%
High Blood Cholesterol: 7 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 10.71%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 10.71%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 10.71%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 10.71%
Cardiac Disorder: 5 people, 8.93%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 8.93%
Diarrhea: 4 people, 7.14%
Pain: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and have Post procedural haemorrhage?

- Check whether Post procedural haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glipizide:

Glipizide (64,852 reports)

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural haemorrhage:

Post procedural haemorrhage (664 drugs)

Browse all the conditions that are associated with Post procedural haemorrhage:

Post procedural haemorrhage (854 conditions)

Related publications that referenced our studies

Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on glipizide (the active ingredients of Glipizide) and Glipizide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.